Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones

The use of fluoroquinolones (FQs) to treat lower respiratory tract infections (LTRI) other than tuberculosis (TB) allows selection of FQ-resistant TB when TB is misdiagnosed. This study maps national guidelines on the use of FQs for LRTI in Europe and determines the risk of FQ-resistant TB upon FQ t...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliori, Giovanni Battista, Langendam, Miranda W., D'Ambrosio, Lia, Centis, Rosella, Blasi, Francesco, Huitric, Emma, Manissero, Davide, van der Werf, Marieke J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2012
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461345/
https://www.ncbi.nlm.nih.gov/pubmed/22653774
http://dx.doi.org/10.1183/09031936.00036812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461345/
https://www.ncbi.nlm.nih.gov/pubmed/22653774
http://dx.doi.org/10.1183/09031936.00036812

Ejemplares similares